BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38141611)

  • 1. Highly cooperative chimeric super-SOX induces naive pluripotency across species.
    MacCarthy CM; Wu G; Malik V; Menuchin-Lasowski Y; Velychko T; Keshet G; Fan R; Bedzhov I; Church GM; Jauch R; Cojocaru V; Schöler HR; Velychko S
    Cell Stem Cell; 2024 Jan; 31(1):127-147.e9. PubMed ID: 38141611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
    Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
    Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
    Srivastava Y; Tan DS; Malik V; Weng M; Javed A; Cojocaru V; Wu G; Veerapandian V; Cheung LWT; Jauch R
    FEBS J; 2020 Jan; 287(1):122-144. PubMed ID: 31569299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
    An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
    Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency.
    Tapia N; MacCarthy C; Esch D; Gabriele Marthaler A; Tiemann U; Araúzo-Bravo MJ; Jauch R; Cojocaru V; Schöler HR
    Sci Rep; 2015 Aug; 5():13533. PubMed ID: 26314899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17.
    Hu H; Ho DHH; Tan DS; MacCarthy CM; Yu CH; Weng M; Schöler HR; Jauch R
    Nucleic Acids Res; 2023 Sep; 51(17):8934-8956. PubMed ID: 37607832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
    Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
    Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
    Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
    Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
    Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
    Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.
    Wang G; Guo X; Hong W; Liu Q; Wei T; Lu C; Gao L; Ye D; Zhou Y; Chen J; Wang J; Wu M; Liu H; Kang J
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2858-63. PubMed ID: 23386720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
    Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
    Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2.
    Malik V; Glaser LV; Zimmer D; Velychko S; Weng M; Holzner M; Arend M; Chen Y; Srivastava Y; Veerapandian V; Shah Z; Esteban MA; Wang H; Chen J; Schöler HR; Hutchins AP; Meijsing SH; Pott S; Jauch R
    Nat Commun; 2019 Aug; 10(1):3477. PubMed ID: 31375664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
    Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
    Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
    Liu P; Chen M; Liu Y; Qi LS; Ding S
    Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing Between Endodermal and Pluripotent Stem Cell Lines During Somatic Cell Reprogramming.
    Moauro A; Ralston A
    Methods Mol Biol; 2022; 2429():41-55. PubMed ID: 35507154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
    Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
    Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
    Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
    PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation.
    Schmidt R; Plath K
    Genome Biol; 2012 Oct; 13(10):251. PubMed ID: 23088445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.